The £3 Miracle Pill  promises to reduce alcohol intake.

Health Needs
miracle pill

3 Responses

Leave a Reply

Your email address will not be published. Required fields are marked *

Drugs have been hailed for lessening desire.
Having been hailed for helping individuals cut back on their alcohol use, a £3 miracle pill has been dubbed the “Ozempic for drinking”.

Usually used to treat alcohol consumption or opioid use disorder by lowering cravings and sensations of euphoria connected with substance use disorder, naltrexone is the medicine in issue.
Since the medication helps battle cravings, taking an hour before drinking alcohol can have a great success rate in persuading people to dramatically cut back on how much alcohol they intake.


The World Health Organisation took a historic public health action in 2023 acknowledging the public health burden linked with alcohol use disorders and now advises the drugs of acamprosate and naltrexone to assist with the management of drinking problems.


The company claims that alcohol use causes three million deaths worldwide annually and causes poor health in millions of individuals. About 150 million of the estimated close to 300 million individuals living with alcohol use disorders globally are thought to be alcohol dependent.


Writing in The Telegraph, journalist Annabel Fenwick Elliott spoke about her own experience of receiving a treatment course that entailed taking naltrexone to lower her alcohol intake.
She said, “When I discovered, first through research and then from experimenting with it personally, that this pill works – in such an astoundingly simple way – like ibuprofen for headaches – I was baffled as to why it isn’t common knowledge.”


The journalist linked it to the effects of Ozempic, the weight loss injection and diabetic treatment that can restrict a person’s appetite.
“What I have found is, I believe, a bit like Ozempic but for people who drink too much, rather than those who oveeat.”
Writing about her experience, Fenwick Elliot wrote: “An hour after I first took the pill, I poured a glass of wine and was astounded by the results. It looked like wine. It tasted like wine. It produced the same modest relaxation effect, but the euphoria didn’t kick in.

I kept taking another sip, expecting for the chain reaction to shoot off; the one that typically carries me to the end of the bottle, but it never did. I took a larger swallow, then half an hour later, did something I hadn’t done in as long as I can remember — I tipped the rest down the sink.”


The journalist states that while she was receiving the treatment ended up “turning down” offers of alcoholic beverages when attending social occasions because she “genuinely didn’t feel like one”.
The way of limiting alcohol intake is termed the Sinclair way, which uses naltrexone as an off-switch for problem drinkers.

The premise is that the drinker keeps drinking while also taking naltrexone, as pioneered by Dr David Sinclair, who was an expert in alcohol addiction and worked at the Finnish Foundation for Alcohol Studies.
The drug was first licensed in 1984, but it is difficult for GPs to prescribe in the UK due to licensing concerns around the treatment.
The technique of therapy is not given by the NHS, but in the UK, it be accessible through a private clinic, which also offers addiction counselling.

Usually used to treat alcohol consumption or opioid use disorder by lowering cravings and sensations of euphoria connected with substance use disorder, naltrexone is the medicine in issue.
Since the medication helps battle cravings, taking an hour before drinking alcohol can have a great success rate in persuading people to dramatically cut back on how much alcohol they intake.


The World Health Organisation took a historic public health action in 2023 acknowledging the public health burden linked with alcohol use disorders and now advises the drugs of acamprosate and naltrexone to assist with the management of drinking problems.


The company claims that alcohol use causes three million deaths worldwide annually and causes poor health in millions of individuals. About 150 million of the estimated close to 300 million individuals living with alcohol use disorders globally are thought to be alcohol dependent.


Writing in The Telegraph, journalist Annabel Fenwick Elliott spoke about her own experience of receiving a treatment course that entailed taking naltrexone to lower her alcohol intake.
She said, “When I discovered, first through research and then from experimenting with it personally, that this pill works – in such an astoundingly simple way – like ibuprofen for headaches – I was baffled as to why it isn’t common knowledge.”


The journalist linked it to the effects of Ozempic, the weight loss injection and diabetic treatment that can restrict a person’s appetite.
“What I have found is, I believe, a bit like Ozempic but for people who drink too much, rather than those who oveeat.”
Writing about her experience, Fenwick Elliot wrote: “An hour after I first took the pill, I poured a glass of wine and was astounded by the results. It looked like wine. It tasted like wine. It produced the same modest relaxation effect, but the euphoria didn’t kick in.

I kept taking another sip, expecting for the chain reaction to shoot off; the one that typically carries me to the end of the bottle, but it never did. I took a larger swallow, then half an hour later, did something I hadn’t done in as long as I can remember — I tipped the rest down the sink.”
The journalist states that while she was receiving the treatment ended up “turning down” offers of alcoholic beverages when attending social occasions because she “genuinely didn’t feel like one”.

The way of limiting alcohol intake is termed the Sinclair way, which uses naltrexone as an off-switch for problem drinkers. The premise is that the drinker keeps drinking while also taking naltrexone, as pioneered by Dr David Sinclair, who was an expert in alcohol addiction and worked at the Finnish Foundation for Alcohol Studies.


The drug was first licensed in 1984, but it is difficult for GPs to prescribe in the UK due to licensing concerns around the treatment.
The technique of therapy is not given by the NHS, but in the UK, it be accessible through a private clinic, which also offers addiction counselling.

Facebook
Twitter
LinkedIn
Telegram
WhatsApp